COSIBELIMAB

UNII:	PNW7GBB44P
Formula:
Preferred Substance Name:	COSIBELIMAB

2216751-26-5
ANTI-PD-L1 MONOCLONAL ANTIBODY CK-301
CK-301
COSIBELIMAB [INN]
COSIBELIMAB [USAN]
COSIBELIMAB [WHO-DD]
COSIBELIMAB IPDL [WHO-DD]
COSIBELIMAB-IPDL
IMMUNOGLOBULIN G1, ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMAN MONOCLONAL CK-301 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CK-301 .LAMBDA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-LAMBDA, ANTI-(HOMO SAPIENS PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1, CD274 ANTIGEN))HUMAN MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-450) (HOMO SAPIENS VH (IGHV1-69*01 (94%) (IGHD)-IGHJ1*01) (8.8.13) (1-120)-HOMO SAPIENS IGHG1*01 (121-450)) (223-217')-DISULFIDE WITH .LAMBDA. LIGHT CHAIN (1'-218') (HOMO SAPIENS V-LAMBDA (IGLV6-57*03 (98%) IGLJ2*01 (92%))(8.3.11) (1'-112')-HOMO SAPIENS IGLC2*01 (113'-218')), DIMER (229-229'':232-232'')-BISDISULFIDE
TG-1501
UNLOXCYT

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

COSIBELIMAB

Synonyms and Mappings

Resources